Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/9142
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | - |
dc.contributor.author | TANIGUCHI, Leandro Utino | - |
dc.contributor.author | CORREIA, Mario Diego Teles | - |
dc.contributor.author | ZAMPIERI, Fernando Godinho | - |
dc.date.accessioned | 2015-04-22T22:20:34Z | - |
dc.date.available | 2015-04-22T22:20:34Z | - |
dc.date.issued | 2014 | - |
dc.identifier.citation | SURGICAL INFECTIONS, v.15, n.6, p.686-693, 2014 | - |
dc.identifier.issn | 1096-2964 | - |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/9142 | - |
dc.description.abstract | Background: Almost 100 years have passed since the first evidence appeared of the immunologic function of the spleen against infections. The spleen now is recognized as the host for immune cells essential for antibody production and elimination of blood-borne pathogens, particularly encapsulated bacteria. Since the early 1900s, splenectomy has been a frequently performed surgical procedure with multiple indications. Unfortunately, removal of the spleen is associated with increased susceptibility to infection, which may be life-long, and death. Methods: Review of the pertinent English-language literature. Results: Splenectomized patients are predisposed to overwhelming fulminant infections caused by encapsulated bacteria that are refractory to the usual treatment, with a case-fatality rate of 40% to 54%. Recent studies demonstrate high morbidity. Conclusions: Because of this high mortality rate and the challenging treatment, prevention of infection by vaccination is a key feature of the management of splenectomized adult patients. | - |
dc.language.iso | eng | - |
dc.publisher | MARY ANN LIEBERT, INC | - |
dc.relation.ispartof | Surgical Infections | - |
dc.rights | restrictedAccess | - |
dc.subject.other | pneumococcal polysaccharide vaccine | - |
dc.subject.other | population-based cohort | - |
dc.subject.other | sickle-cell-anemia | - |
dc.subject.other | human septic shock | - |
dc.subject.other | memory b-cells | - |
dc.subject.other | splenic function | - |
dc.subject.other | streptococcus-pneumoniae | - |
dc.subject.other | increased susceptibility | - |
dc.subject.other | splenectomized patients | - |
dc.subject.other | antimicrobial therapy | - |
dc.title | Overwhelming Post-Splenectomy Infection: Narrative Review of the Literature | - |
dc.type | article | - |
dc.rights.holder | Copyright MARY ANN LIEBERT, INC | - |
dc.identifier.doi | 10.1089/sur.2013.051 | - |
dc.identifier.pmid | 25318011 | - |
dc.subject.wos | Infectious Diseases | - |
dc.subject.wos | Surgery | - |
dc.type.category | review | - |
dc.type.version | publishedVersion | - |
hcfmusp.description.beginpage | 686 | - |
hcfmusp.description.endpage | 693 | - |
hcfmusp.description.issue | 6 | - |
hcfmusp.description.volume | 15 | - |
hcfmusp.origem | WOS | - |
hcfmusp.origem.id | 2-s2.0-84918545657 | - |
hcfmusp.origem.id | WOS:000346335500004 | - |
hcfmusp.publisher.city | NEW ROCHELLE | - |
hcfmusp.publisher.country | USA | - |
hcfmusp.relation.reference | [Anonymous], 2012, VACCINE, V30, P4717 | - |
hcfmusp.relation.reference | Bisharat N, 2001, J INFECTION, V43, P182, DOI 10.1053/jinf.2001.0904 | - |
hcfmusp.relation.reference | BISNO AL, 1970, ANN INTERN MED, V72, P389 | - |
hcfmusp.relation.reference | GOPAL V, 1977, ARCH INTERN MED, V137, P1526, DOI 10.1001/archinte.137.11.1526 | - |
hcfmusp.relation.reference | Brigden ML, 2001, AM FAM PHYSICIAN, V63, P499 | - |
hcfmusp.relation.reference | Brigden ML, 2000, AM J HEMATOL, V65, P25, DOI 10.1002/1096-8652(200009)65:1<25::AID-AJH4>3.0.CO;2-8 | - |
hcfmusp.relation.reference | Cameron PU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023164 | - |
hcfmusp.relation.reference | CANCADO R. D., 2007, REV BRAS HEMATOL HEM, V29, P203 | - |
hcfmusp.relation.reference | Cherif H, 2006, VACCINE, V24, P75, DOI 10.1016/j.vaccine.2005.07.054 | - |
hcfmusp.relation.reference | Chotivanich K, 2002, J INFECT DIS, V185, P1538, DOI 10.1086/340213 | - |
hcfmusp.relation.reference | Coignard-Biehler Hélène, 2011, J Infect Public Health, V4, P187, DOI 10.1016/j.jiph.2011.06.004 | - |
hcfmusp.relation.reference | COIL JA, 1978, INFECT IMMUN, V21, P412 | - |
hcfmusp.relation.reference | CONSTANT.A, 1973, AM J DIS CHILD, V125, P663 | - |
hcfmusp.relation.reference | CORAZZA GR, 1981, CLIN SCI, V60, P109 | - |
hcfmusp.relation.reference | CORAZZA GR, 1990, CLIN LAB HAEMATOL, V12, P269 | - |
hcfmusp.relation.reference | Davidson RN, 2001, CLIN MICROBIOL INFEC, V7, P657, DOI 10.1046/j.1198-743x.2001.00355.x | - |
hcfmusp.relation.reference | Davies JM, 2002, CLIN MED, V2, P440 | - |
hcfmusp.relation.reference | Davies JM, 2011, BRIT J HAEMATOL, V155, P308, DOI 10.1111/j.1365-2141.2011.08843.x | - |
hcfmusp.relation.reference | Dellinger RP, 2013, INTENS CARE MED, V39, P165, DOI 10.1007/s00134-012-2769-8 | - |
hcfmusp.relation.reference | Demetriades D, 2012, J TRAUMA ACUTE CARE, V72, P229, DOI 10.1097/TA.0b013e31823fe0b6 | - |
hcfmusp.relation.reference | Dendle C, 2012, MED J AUSTRALIA, V196, P582, DOI 10.5694/mja11.10909 | - |
hcfmusp.relation.reference | de Porto APNA, 2010, EUR J CLIN MICROBIOL, V29, P1465, DOI 10.1007/s10096-010-1049-1 | - |
hcfmusp.relation.reference | Dial S, 2008, CAN MED ASSOC J, V179, P767, DOI 10.1503/cmaj.071812 | - |
hcfmusp.relation.reference | DIAMOND LK, 1969, PEDIATRICS, V43, P886 | - |
hcfmusp.relation.reference | Di Sabatino A, 2011, LANCET, V378, P86, DOI 10.1016/S0140-6736(10)61493-6 | - |
hcfmusp.relation.reference | EICHNER ER, 1979, AM J MED, V66, P311, DOI 10.1016/0002-9343(79)90554-0 | - |
hcfmusp.relation.reference | Eighner ER, 1979, AM J MED, V66, P311 | - |
hcfmusp.relation.reference | Ejstrud P, 2000, SCAND J INFECT DIS, V32, P521, DOI 10.1080/003655400458811 | - |
hcfmusp.relation.reference | El-Alfy MS, 2004, HEMATOL J, V5, P77, DOI 10.1038/sj.thj.6200328 | - |
hcfmusp.relation.reference | Garnacho-Montero J, 2003, CRIT CARE MED, V31, P2742, DOI 10.1097/01.CCM.0000098031.24329.10 | - |
hcfmusp.relation.reference | GASTON MH, 1986, NEW ENGL J MED, V314, P1593, DOI 10.1056/NEJM198606193142501 | - |
hcfmusp.relation.reference | Gotthardt M, 2007, NUKLEARMED-NUCL MED, V46, P135, DOI 10.1160/nukmed-0063 | - |
hcfmusp.relation.reference | HOLDSWORTH RJ, 1991, BRIT J SURG, V78, P1031, DOI 10.1002/bjs.1800780904 | - |
hcfmusp.relation.reference | HOSEA SW, 1981, LANCET, V1, P804 | - |
hcfmusp.relation.reference | Howdieshell Thomas R, 2006, Surg Infect (Larchmt), V7, P275, DOI 10.1089/sur.2006.7.275 | - |
hcfmusp.relation.reference | JANDL JH, 1957, J CLIN INVEST, V36, P1428, DOI 10.1172/JCI103542 | - |
hcfmusp.relation.reference | JOHN AB, 1984, BRIT MED J, V288, P1567 | - |
hcfmusp.relation.reference | Jones P, 2010, AUST FAM PHYSICIAN, V39, P383 | - |
hcfmusp.relation.reference | KING H, 1952, ANN SURG, V136, P239 | - |
hcfmusp.relation.reference | Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679 | - |
hcfmusp.relation.reference | Koppel EA, 2005, EUR J IMMUNOL, V35, P2962, DOI 10.1002/eji.200526216 | - |
hcfmusp.relation.reference | Krause PJ, 2008, CLIN INFECT DIS, V46, P370, DOI 10.1086/525852 | - |
hcfmusp.relation.reference | Kruetzmann S, 2003, J EXP MED, V197, P939, DOI 10.1084/jem.20022020 | - |
hcfmusp.relation.reference | Kumar A, 2009, CHEST, V136, P1237, DOI 10.1378/chest.09-0087 | - |
hcfmusp.relation.reference | Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1016/j.ccc.2009.08.004 | - |
hcfmusp.relation.reference | Kyaw MH, 2006, AM J MED, V119, pe1, DOI 10.1016/J.AMJMED.2005.07.044 | - |
hcfmusp.relation.reference | Lammers AJ, 2011, IMMUNOBIOLOGY, V216, P863, DOI 10.1016/j.imbio.2011.02.004 | - |
hcfmusp.relation.reference | Lammers AJJ, 2010, EUR J CLIN MICROBIOL, V29, P399, DOI 10.1007/s10096-009-0870-x | - |
hcfmusp.relation.reference | LIKHITE VV, 1976, JAMA-J AM MED ASSOC, V236, P1376, DOI 10.1001/jama.236.12.1376 | - |
hcfmusp.relation.reference | Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669 | - |
hcfmusp.relation.reference | Morris DH, 1919, ANN SURG, V70, P513, DOI 10.1097/00000658-191911000-00001 | - |
hcfmusp.relation.reference | Mourtzoukou EG, 2008, BRIT J SURG, V95, P273, DOI 10.1002/bjs.6106 | - |
hcfmusp.relation.reference | Musher DM, 2005, J INFECT DIS, V191, P1063, DOI 10.1086/428135 | - |
hcfmusp.relation.reference | Okabayashi T, 2008, WORLD J GASTROENTERO, V14, P176, DOI 10.3748/wjg.14.176 | - |
hcfmusp.relation.reference | PEARSON HA, 1969, NEW ENGL J MED, V281, P923, DOI 10.1056/NEJM196910232811703 | - |
hcfmusp.relation.reference | Pedersen G, 2003, CLIN MICROBIOL INFEC, V9, P793, DOI 10.1046/j.1469-0691.2003.00599.x | - |
hcfmusp.relation.reference | Rogers ZR, 2011, BLOOD, V117, P2614, DOI 10.1182/blood-2010-04-278747 | - |
hcfmusp.relation.reference | Rose MA, 2005, CLIN DIAGN LAB IMMUN, V12, P1216, DOI 10.1128/CDLI.12.10.1216-1222.2005 | - |
hcfmusp.relation.reference | ROWLEY DA, 1950, J IMMUNOL, V65, P515 | - |
hcfmusp.relation.reference | Rytel MW, 1974, AM J MED, V57, P884 | - |
hcfmusp.relation.reference | Saeland E, 2003, J IMMUNOL, V170, P6158 | - |
hcfmusp.relation.reference | SCHULKIN.ML, 1967, PEDIATR RES, V1, P178, DOI 10.1203/00006450-196705000-00004 | - |
hcfmusp.relation.reference | Shatz DV, 1998, J TRAUMA, V44, P760, DOI 10.1097/00005373-199805000-00004 | - |
hcfmusp.relation.reference | Shih-Ching Kang, 2004, Cytokine, V28, P101, DOI 10.1016/j.cyto.2004.07.005 | - |
hcfmusp.relation.reference | Siber GR, 2007, VACCINE, V25, P3816, DOI 10.1016/j.vaccine.2007.01.119 | - |
hcfmusp.relation.reference | Spier Z, 1980, ARCH DIS CHILD, V55, P566 | - |
hcfmusp.relation.reference | SPIRER Z, 1977, BRIT MED J, V2, P1574 | - |
hcfmusp.relation.reference | Stanford E, 2009, HUM VACCINES, V5, P85 | - |
hcfmusp.relation.reference | Theilacker C, 2011, INTENSIVE NEWS, V1, P11 | - |
hcfmusp.relation.reference | Thomsen RW, 2009, ANN INTERN MED, V151, P546 | - |
hcfmusp.relation.reference | TORRES J, 1973, AM J MED, V55, P851, DOI 10.1016/0002-9343(73)90268-4 | - |
hcfmusp.relation.reference | Waghorn DJ, 2001, J CLIN PATHOL, V54, P214, DOI 10.1136/jcp.54.3.214 | - |
hcfmusp.relation.reference | Wardemann H, 2002, J EXP MED, V195, P771, DOI 10.1084/jem.20011140 | - |
hcfmusp.relation.reference | WHITE KS, 1991, AM J INFECT CONTROL, V19, P36, DOI 10.1016/0196-6553(91)90158-9 | - |
hcfmusp.relation.reference | William BM, 2007, HEMATOLOGY, V12, P1, DOI 10.1080/10245330600938422 | - |
hcfmusp.relation.reference | William BM, 2007, HEMATOLOGY, V12, P89, DOI 10.1080/10245330600938463 | - |
hcfmusp.relation.reference | Williams TN, 2009, LANCET, V374, P1364, DOI 10.1016/S0140-6736(09)61374-X | - |
hcfmusp.relation.reference | Working Party of the British Committee for Standards in Haematology Clinical Haematology Task Force, 1996, BRIT MED J, V312, P430 | - |
hcfmusp.relation.reference | World Health Organization, REC ASS QUAL SAF EFF | - |
hcfmusp.relation.reference | Yong M, 2010, EUR J INTERN MED, V21, P12, DOI 10.1016/j.ejim.2009.10.003 | - |
dc.description.index | MEDLINE | - |
dc.identifier.eissn | 1557-8674 | - |
hcfmusp.citation.scopus | 17 | - |
hcfmusp.scopus.lastupdate | 2024-03-29 | - |
Appears in Collections: | Artigos e Materiais de Revistas Científicas - HC/ICHC Artigos e Materiais de Revistas Científicas - LIM/51 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
art_TANIGUCHI_Overwhelming_PostSplenectomy_Infection_Narrative_Review_of_the_Literature_2014.PDF Restricted Access | publishedVersion (English) | 168.47 kB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.